Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections
Abstract AS01-adjuvanted shingles (herpes zoster) vaccination is associated with a lower risk of dementia, but the underlying mechanisms are unclear. In propensity-score matched cohort studies with 436,788 individuals, both the AS01-adjuvanted shingles and respiratory syncytial virus (RSV) vaccines,...
Saved in:
| Main Authors: | Maxime Taquet, John A. Todd, Paul J. Harrison |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-06-01
|
| Series: | npj Vaccines |
| Online Access: | https://doi.org/10.1038/s41541-025-01172-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recommendations for vaccination against shingles
by: Zuzanna Wyleciał, et al.
Published: (2025-01-01) -
Characteristics of the First Italian Older Adults Vaccinated with an Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine
by: Alexander Domnich, et al.
Published: (2025-01-01) -
Enhanced safety surveillance of the adjuvanted respiratory syncytial virus vaccine among Italian older adults
by: Alexander Domnich, et al.
Published: (2025-06-01) -
Respiratory Syncytial Virus Vaccine Induced Thrombotic Microangiopathy
by: Seby R, et al.
Published: (2025-07-01) -
Bivalent vaccines effectively protect mice against influenza A and respiratory syncytial viruses
by: Sathya N. Thulasi Raman, et al.
Published: (2023-12-01)